Rosetta Genomics Ltd. engages in the provision of therapeutic, diagnostic product development, and medical research services. The firm is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY, and RosettaGX Reveal. The firm's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The firm focuses on developing a diagnostic assay, RosettaGX Reveal V2. The company is also focusing on developing Bladder cancer risk stratification.
Follow-Up Questions
Rosetta Genomics Ltd (ROSGQ) 的市盈率是多少？
Rosetta Genomics Ltd 的市盈率是 0
ROSGQ 股票的价格表现如何？
ROSGQ 的当前价格为 $0.0001，在上个交易日 decreased 了 0%。
Rosetta Genomics Ltd 的主要业务主题或行业是什么？
Rosetta Genomics Ltd 属于 Biotechnology 行业，该板块是 Health Care
